Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medibank Private ( (AU:MPL) ) just unveiled an update.
Medibank has announced the retirement of The Hon Jay Weatherill AO as a non-executive director, effective 31 December 2025, and has lodged a Final Director’s Interest Notice with the ASX in accordance with listing requirements. The filing confirms that Weatherill held no Medibank securities in his own name at the time of ceasing to be a director, indicating no direct equity stake remains tied to his tenure and signalling a clean governance transition for the board and its stakeholders.
The most recent analyst rating on (AU:MPL) stock is a Buy with a A$5.50 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is an Australian private health insurer providing health insurance and related services to individuals and families across the country. Listed on the ASX, the company operates in the healthcare and insurance industry, focusing on private health cover and associated health services for its policyholders.
YTD Price Performance: 0.42%
Average Trading Volume: 5,680,125
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$13.25B
For an in-depth examination of MPL stock, go to TipRanks’ Overview page.